Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-054351

Chief Financial Officer sold 30,000 shares at an average $50.65 ($1,519,429)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-10-08 Option exercise +30,000 $6.32 $189,600 31,000 D
Cohen Chad M Chief Financial Officer 2020-10-08 Sale −23,746 $50.46 $1,198,223 7,254 D
Cohen Chad M Chief Financial Officer 2020-10-08 Sale −6,254 $51.36 $321,205 1,000 D
Derivatives
Cohen Chad M Chief Financial Officer 2020-10-08 Option exercise · Stock Option (Right To Buy) −30,000 550,000 D
Open-market sales · 30,000 sh · avg $50.65 · $1,519,429
Loading xslF345X03/doc4.xml…